Image Credit: Health and me
There's been an alarming increase of respiratory and gastrointestinal viruses in the United States lately, causing anxiety about a so-called "quad-demic". According to surveillance reports, influenza, COVID-19, RSV and norovirus are at very high levels everywhere. While the surge aligns with patterns typical for this season, several epidemiologists view simultaneous infections of such proportions to pose risks not only to individual healthcare but public health.
The incidence of the quad-demic should vary with seasonal patterns, vaccination rates, and public health interventions. Each virus alone is relatively easy to manage; however, the effect of all together could lead to overburdening of health care facilities and increase risks for those at higher risk. Continuing surveillance, early testing, and proactive prevention measures will play an important role in the control of these infections going forward.
While the term "quad-demic" sounds daunting, it must be taken into perspective. For years, we have had all these viruses together, and we have the capabilities to mitigate some of the risk. Vaccination, proper hygiene and using common sense helps individuals get through the season unscathed. Is the quad-demic a permanent fixture or just another seasonal wave? Let's break this down.
Typically, flu, COVID-19, and RSV have been the primary culprits behind seasonal respiratory infections. However, norovirus, a highly contagious stomach bug, has emerged as a fourth significant player, inducing fears of a more severe and widespread viral outbreak. According to the Centers for Disease Control and Prevention (CDC), the U.S. recorded nearly 500 norovirus outbreaks between August and December 2023, a substantial rise from the previous year’s numbers.
While the term "quad-demic" may sound ominous, the seriousness and consequences of such infections should be weighed in light of the U.S. healthcare system's experience with managing viral surges since the start of the COVID-19 pandemic.
Flu continues to be one of the most common and alarming seasonal illnesses. In the period spanning from 2023 to 2024, there were approximately 40 million cases of flu, and thousands of hospitalizations along with reported 47 deaths have been reported this season. Flu symptoms include fever, chills, cough, sore throat, muscle pain, and fatigue, with most recovering within a week or two but risky factors for severe illness effects occur in young children, elderly, and people with chronic conditions.
Despite its reduction from the first pandemic peak, COVID-19 is still rampant. The CDC estimates that alone between October and December 2023, there were between 2.7 and 5 million cases in the U.S. Hospitalization has increased by cities such as Los Angeles, Chicago, and New York. Symptoms are closely similar to the flu, fever, cough, and fatigue but uniquely presents in some cases as loss of taste and smell.
RSV is the most common cause of lower respiratory infections in infants, older adults, and immunocompromised individuals. While RSV peaked late in 2023 and early 2024, it continues to be a threat because it can lead to bronchiolitis and pneumonia. It is very similar to the common cold, presenting with symptoms such as congestion, runny nose, coughing, and fever, which can make it difficult to differentiate from flu or COVID-19 without testing.
Norovirus, also called the "stomach flu," is a highly contagious infection of the gastrointestinal tract, not a respiratory virus. It transmits quickly from contaminated food and water and contact with contaminated surfaces, causing such symptoms as diarrhea, vomiting, nausea, and stomach pain. Cases have shot up, the CDC said Monday, with reports of outbreaks surging compared with last year.
The greatest challenge during the quad-demic is how the four viruses are alike and thus make identification very hard with no testing applied. Most cases present symptoms common to all viruses: fever, tiredness, body pains, and respiratory, which includes coughing and congestions for influenza, COVID-19, and RSV; the other would be norovirus symptoms as nausea and vomiting can appear even in extreme influenza and COVID-19. This overlap increases the risk of misdiagnosis and delayed treatment, hence the need for early testing and proper medical guidance.
Also Read: Is US Preparing For A Quad- demic 2025?
The best defense against these viruses is a combination of vaccines, hygiene, and lifestyle precautions. While lifestyle modifications are highlighted as part of the constant need to eat healthy, ensure daily movement and drinking adequate amount of fluids. There is a sure short two preventive strategies that are effective:
While debates on masked wear continue on, experts on mask-wear affirm that this does not only have a historical precedent but works towards reducing airborne viruses spreading within the environments. Hospitals, though, ensure masking in key sections of themselves. Publicized mask-wear remains a discretion, though massing indoors still goes a longer way in cases like peak flu seasons.
If you notice the symptoms of these viruses, then it's best to be confined at home and avoid having face-to-face interaction with others and seek immediate attention from your physician if your condition worsens. Quarantining for some days can decrease the spread of infection.
As we move into the first half of 2025 and beyond, staying informed and proactive is the best strategy for maintaining health and avoiding unnecessary panic. The key takeaway? Stay vigilant, but don’t be alarmed—these viruses are here, but so are the means to fight them.
Credit: Audrey Leishman/Instagram
Audrey Leishman, wife of professional golfer Marc Leishman, initially believed she was suffering from the flu after developing common flu-like symptoms. However, her condition rapidly worsened and was later diagnosed as sepsis, a life-threatening medical emergency.
The Virginia woman nearly lost her life, spending 10 days in the intensive care unit (ICU). Following the ordeal, she faced a long recovery and had to relearn how to walk, Fox News reported. Now recovered, Leishman is dedicated to raising awareness about the condition through her nonprofit organization, the Begin Again Foundation. She has also written a children's book aimed at helping families recognize the warning signs.
Leishman faced the ordeal in 2015. She started experiencing symptoms of what she initially thought was an upset stomach a couple of days after having her intrauterine device (IUD) removed, according to the nonprofit Sepsis Alliance.
The next day, the mother of three said she began feeling unwell, experiencing stomach cramps and "severe pain in my right elbow and left big toe," along with a high fever, nosebleeds, diarrhea, and shortness of breath. "I could barely hold my 18-month-old son because I was so weak. My temperature was 102°F," Leishman said.
She eventually went to urgent care, where doctors initially thought she had some form of an autoimmune disease, Fox News reported. As the days went on, Leishman started to feel worse. Her fever spiked higher, and she developed severe stomach issues. "I actually thought I was going a little bit crazy … I hadn't injured myself. I was really confused as to what was going on," Leishman said.
"They took a very long time to figure out what was going wrong with me." "They kept testing me for different things," she continued. "Eventually, they admitted me, and I was in the ICU for a total of 10 days — five of which were in a medically induced coma." During this time, her temperature and heart rate were abnormally high, and her blood pressure was dangerously low.
The sepsis ultimately developed into acute respiratory distress syndrome. "I very much remember not being able to breathe," Leishman recalled. "That was by far the scariest part. It got to the point where I had to pause between every word to take a breath, and it was basically like sipping air."
Leishman was eventually diagnosed with sepsis and toxic shock syndrome (TSS), according to Sepsis Alliance.
While she did recover, she was unable to walk, and the first year of recovery was "very difficult." "When I finally did wake up, it was quite the process of relearning how to walk again, dealing with at-home physical therapy and being on a PICC line (peripherally inserted central catheter)," Leishman said.
"My immune system was so compromised that I was sick constantly," she added, noting that although she is now healthy, her memory "is not what it used to be" and that she gets fatigued more often. The original cause of her sepsis remains unclear, she said, but it may have been linked to her recent IUD removal.
Sepsis is a life-threatening reaction to an infection that harms the immune system, tissues, and organs. It can lead to organ failure or death if not treated urgently, according to the Cleveland Clinic.
According to Sepsis Alliance, the acronym TIME can help people recognize potential warning signs of sepsis and seek urgent medical care.
T — Temperature: Body temperature is unusually high or low.
I — Infection: Signs or symptoms of an infection are present.
M — Mental Decline: Confusion, excessive sleepiness, or difficulty waking up.
E — Extremely Ill: Severe pain, extreme discomfort, or shortness of breath.
Credit: Canva
Health authorities of the United Kingdom have confirmed that there is a confirmed case of meningitis at the University of Surrey, where a student has been infected with it. Meningitis is one of the most dangerous diseases and containing it comes first for the health authorities.
The UK Health Security Agency (UKHSA) is working to provide preventative antibiotics and vaccinations for close contacts. The authorities are giving great importance to this because of the two earlier deaths in Kent this year.
Jaime Morgan, from UKHSA South East, said: "We understand that news of meningococcal infection can be concerning. However, meningococcal meningitis requires very close contact to spread." She added, "We are working closely with partners and have provided public health advice to close contacts of the case."
Morgan also said that meningococcal disease is known not to spread easily among people, thus a larger possibility of public health loss is unlikely. She also urged the students at the university to be aware of symptoms and to seek medical advice if needed.
Also Read: Why Thousands Of Black Men In The UK Are Now Being Invited For Prostate Cancer Screening?
Meningitis is an infection of the protective membranes around the spinal cord and the brain. It can become very serious if not treated or diagnosed in time. It is a consequence of bacterial or viral infection. Despite being a rare occurrence, the infection can spread through coughs, sneezes, a cold, or physical contact in the form of kissing.
Understanding the symptoms, causes, and treatment options is important for early diagnosis and timely medical care.
Health officials urged the public to remain alert to the warning signs of meningococcal meningitis. Common symptoms include:
Physicians diagnose meningitis using a combination of clinical presentation, laboratory examinations, and imaging tests. Important diagnostic tests are Lumbar Puncture (Spinal Tap), Blood Cultures, and Imaging (CT or MRI Scans).
Though Meningitis is not the only problem of the UKHSA now. Along with other global issues, the United Kingdom is also facing a certain rise in cases of botulism, which is a dreadful disease caused by bacteria and can cause difficulty in breathing, paralysis, and even death. According to the United Kingdom Health Security Agency (UKHSA), recently, two more people from Leeds have come forward with symptoms of this fatal disease.
Last week, a small number of people with symptoms of botulism presented to the National Health Service (NHS) around Leeds. These people observed botulism signs after aesthetic treatments involving botulinum toxin. After a sudden increase in patients of this dreadful disease, the authorities are on alert.
UKHSA urged people to take precautions when seeking cosmetic procedures and has advised medical staff to look out for possible botulism in people who have had recent treatments and have symptoms.
Credit: Canva
A team of UK scientists has identified 23 unique mutations in the ongoing Ebola outbreak in the Democratic Republic of Congo (DRC) and Uganda, led by the Bundibugyo virus.
The findings, led by scientists from Imperial College London and the University of Oxford, are based on an analysis of 10 available Bundibugyo virus sequences from the Congo and Uganda associated with the current 2026 outbreak, according to Virological.org — an online discussion forum for pathogenic virus sequence data. The forum was launched in November 2014.
The sampled viruses appear to share a most recent common ancestor dating to early-to-mid March 2026, the researchers said.
"The sampled viruses are already genetically diverse. We identified 23 unique mutations across the 10 sequences," said Gina Cuomo-Dannenburg from Imperial College London and Mahan Ghafari from the University of Oxford.
"This level of diversity suggests that the sampled viruses do not represent the very beginning of transmission, but instead reflect an outbreak that had already been circulating, at least partly undetected, for several weeks before sequences became available," they added.
However, the authors noted that "this is an informal analysis and is not intended as a formal preprint or manuscript in its current form" and urged that the estimates "should be interpreted cautiously."
Meanwhile, Congo said on Sunday that the number of confirmed Ebola cases had increased to 515 after 27 new samples tested positive in the previous 24 hours. The confirmed cases include 91 deaths, government data showed.
The Ministry of Health Uganda has confirmed 19 Ebola cases so far, including 14 imported from the DRC and five locally transmitted infections.
According to the World Health Organization, the latest outbreak has resulted in 516 suspected cases and 33 confirmed infections, with as many as 133 deaths reported.
The Ebola outbreak spreading through the Democratic Republic of Congo and Uganda could become more devastating than the largest Ebola epidemic in history unless containment efforts improve, according to modelling released by the US CDC.
The models, published in the Morbidity and Mortality Weekly Report, showed that the current outbreak could rival the scale of the 2014 West Africa outbreak, which resulted in more than 28,000 cases and over 11,000 deaths.
"That scale is possible," said Jason Asher, director of the CDC's Center for Forecasting and Outbreak Analytics, during a press briefing.
The worst outcomes could be avoided if "a larger proportion of patients were identified, isolated, and treated," the agency said in its reports.
However, "the public health response to control this outbreak will likely need to be of similar magnitude to the response for the 2014–2016 West Africa Ebola outbreak."
Also read: WHO Says Ebola Fight Is Catching Up; Expert Explains Science Behind Patient Recoveries
There are currently no approved treatments specifically for Bundibugyo ebolavirus, despite the existence of some antiviral therapies for other Ebola species. The rare strain is known to kill up to 40 percent of infected patients.
Scientists at the US' Southwest Research Institute (SwRI) have used AI-driven drug discovery platforms to rapidly identify and synthesize 23 antiviral candidates targeting the Bundibugyo Ebola strain currently affecting Congo.
The newly identified compounds are expected to undergo testing against the Bundibugyo virus in the coming weeks.
Ebola is a severe and deadly disease caused by a virus mostly found in Africa. The spread of the disease happens through contact with infected body fluids.
Some symptoms can indicate a possible infection. This includes fever, headache, weakness, vomiting, diarrhea, muscle pain, sore throat, and unexplained bleeding. This eventually leads to severe complications like bleeding, organ failure, and death.
© 2024 Bennett, Coleman & Company Limited